Our previous studies showed that inhibition of Skp2 suppressed cell viability, stimulated apoptosis and led to cell cycle arrest, and attenuated cell migrative ability in osteosarcoma cells, whereas overexpression of Skp2 exerted the opposite effects on osteosarcoma cells [25, 26]. Here, SKP2 is linked to osteosarcoma.